Fighting discrimination.
In the fight against discrimination, the IDF launched the first ever International Charter of Rights and Responsibilities of People with Diabetes in 2011: a balance between rights and duties to optimize health and quality of life, to enable as normal a life as possible and to reduce/eliminate the barriers which deny realization of full potential as members of society. It is extremely frustrating to suffer blanket bans and many examples exist, including insurance, driving licenses, getting a job, keeping a job and family affairs. In this article, an example is given of how pilots with insulin treated diabetes are allowed to fly by taking the responsibility of using special blood glucose monitoring protocols. At this time the systems in the countries allowing flying for pilots with insulin treated diabetes are applauded, particularly the USA for private flying, and Canada for commercial flying. Encouraging developments may be underway in the UK for commercial flying and, if this materializes, could be used as an example for other aviation authorities to help adopt similar protocols. However, new restrictions implemented by the new European Aviation Authority take existing privileges away for National Private Pilot Licence holders with insulin treated diabetes in the UK.
International Diabetes Federation IDF Global, IDF Special Ambassador 2010-2012 for the Rights and Responsibilities of People with Diabetes, Vice President IDF Global, Buizerdlaan 211, 2261 CV Leidschendam, The Netherlands. wim.wientjens@wxs.nl
Wim
W
Wientjens
Douglas
D
Cairns
D001291:Attitude of Health Personnel; D001334:Automobile Driving / Q000331:legislation & jurisprudence; D001359:Aviation / Q000331:legislation & jurisprudence; D002170:Canada / Q000453:epidemiology; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology; D004651:Employment / Q000331:legislation & jurisprudence; D005190:Family; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D007341:Insurance / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data*; D008004:Licensure / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data*; D008297:Male; D028701:Patient Rights / Q000331:legislation & jurisprudence*; D011640:Public Policy; D063508:Social Discrimination / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data*; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
D007004:Hypoglycemic Agents; D007328:Insulin